Literature DB >> 23262929

Reevaluation of discriminatory and threshold levels for serum β-hCG in early pregnancy.

AnnaMarie Connolly1, David H Ryan, Alison M Stuebe, Honor M Wolfe.   

Abstract

OBJECTIVES: To reevaluate both discriminatory and threshold levels associated with visualization of gestational sacs, yolk sacs, and fetal poles in patients presenting with vaginal bleeding, pain, or vaginal bleeding and pain in the first trimester of pregnancy using current ultrasonographic technology.
METHODS: We reviewed the records of patients with first-trimester vaginal bleeding, pelvic pain, or both who were evaluated with a serum β-hCG level and a transvaginal ultrasonogram within 6 hours of each other and had a known pregnancy outcome. Discriminatory and threshold β-hCG levels for visualization of a gestational sac, yolk sac, and fetal pole were identified for all ultimately viable pregnancies. Logistic regression was used to model the predicted probability of visualizing these structures as a function of β-hCG values using fractional polynomials.
RESULTS: Six hundred fifty-one pregnancies met inclusion criteria; 366 were viable. Discriminatory β-hCG levels at which structures would be predicted to be seen 99% of the time were 3,510 milli-international units/mL, 17,716 milli-international units/mL, and 47,685 milli-international units/mL for gestational sac, yolk sac, and fetal pole, respectively. In our population, threshold values for β-hCG levels at which these structures could be seen were 390 milli-international units/mL, 1,094 milli-international units/mL, and 1,394 milli-international units/mL, respectively.
CONCLUSIONS: Improvements in ultrasonographic technology have led to lower threshold β-hCG values for ultrasonographic visualization of early intrauterine gestational structures. However, discriminatory levels for serum β-hCG levels were higher than values currently used in practice. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23262929     DOI: 10.1097/aog.0b013e318278f421

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Metabolomic identification of novel diagnostic biomarkers in ectopic pregnancy.

Authors:  Onur Turkoglu; Ayse Citil; Ceren Katar; Ismail Mert; Praveen Kumar; Ali Yilmaz; Dilek S Uygur; Salim Erkaya; Stewart F Graham; Ray O Bahado-Singh
Journal:  Metabolomics       Date:  2019-10-19       Impact factor: 4.290

2.  Temporal refinement does not affect predicted human chorionic gonadotropin rise in early pregnancy.

Authors:  Andrew R Fisher; Mary D Sammel; Suneeta Senapati; Ashley Singer; Kurt T Barnhart
Journal:  Fertil Steril       Date:  2016-04-07       Impact factor: 7.329

3.  A spontaneous bilateral tubal pregnancy: A case report.

Authors:  Hong Xu
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

4.  Pregnancy of unknown location.

Authors:  Pedro Paulo Pereira; Fábio Roberto Cabar; Úrsula Trovato Gomez; Rossana Pulcineli Vieira Francisco
Journal:  Clinics (Sao Paulo)       Date:  2019-10-14       Impact factor: 2.365

5.  Heterotopic pregnancy after a spontaneous conception a case report with a review of clinical, laboratory and imaging findings.

Authors:  Ahmed H Abdelmonem; Gamal Sayed; Abd Elwahid Abugazia; Samah Kohla; Reda Youssef
Journal:  Clin Case Rep       Date:  2021-08-16

6.  Tubal pregnancy in a case of unicornuate uterus with contralateral streak ovary and renal agenesis: A case report.

Authors:  Lauren H Barnts; Taylor J Kratochvil; Sylvia J Ziegenbein
Journal:  Case Rep Womens Health       Date:  2022-03-29

7.  Chinese Obstetrics & Gynecology journal club: a randomised controlled trial.

Authors:  Ilene K Tsui; William C Dodson; Allen R Kunselman; Hongying Kuang; Feng-Juan Han; Richard S Legro; Xiao-Ke Wu
Journal:  BMJ Open       Date:  2016-01-28       Impact factor: 2.692

8.  Endometriosis-induced massive hemoperitoneum misdiagnosed as ruptured ectopic pregnancy: a case report.

Authors:  Bong Hyeon Kim; Seong Nam Park; Byoung Ryun Kim
Journal:  J Med Case Rep       Date:  2020-09-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.